Exposure to SSRI antidepressants in utero causes birth defects, neonatal withdrawal symptoms and brain damage

Article type: Research Article

Authors: Breggin, Peter R. | Breggin, Ginger

Affiliations: 101 East State Street, No. 112, Ithaca, NY 14850, USA

Note: [] Address for correspondence: Dr. P.R. Breggin, Founder and Director, International Center for the Study of Psychiatry and Psychology (1972–2002) and Director Emeritus (2002–present), 101 East State Street, No. 112, Ithaca, NY 14850, USA. Tel.: +1 607 272 5328 or 5354; Fax: +1 607 272 5329; E-mail: [email protected]

Abstract: Pregnant women should avoid taking SSRI antidepressants – they are hazardous to the developing fetus, cause withdrawal symptoms in the newborn baby, and induce biochemical and morphological abnormalities in the brain. If pregnant mothers need help with sad or anxious feelings, they should seek counseling or psychotherapy, especially family therapy involving the child's father, as well as other sources of emotional support.

Keywords: SSRI antidepressants, pregnancy, birth defect

Journal: International Journal of Risk and Safety in Medicine, vol. 19, no. 4, pp. 203-207, 2007